Tularik to Present at Goldman Sachs Healthcare Conference 2002
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--June 6, 2002-- Tularik Inc. (Nasdaq:TLRK - News) announced that David V. Goeddel, Ph.D., Tularik's chief executive officer, is scheduled to report on the company's research and clinical programs at the 23rd Annual Goldman Sachs Healthcare Conference at the Ritz-Carlton, Laguna Niguel in Dana Point, California on Tuesday, June 11, 2002 beginning at 4:40 p.m. Pacific Time.
Tularik's presentation will be webcast live and may be accessed at the URL gs.com. The username will be 'conference/confd' and password will be 'healthcare'. Username and password are case-sensitive and should be all small caps. An archived webcast of the presentation will be available 24 hours after the presentation for a period of two months.
About Tularik
Tularik is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform spans seven disease-based programs focused on three areas: cancer, immunology and metabolic disease. For more information, visit Tularik's Internet website at www.tularik.com.
Contact:
Tularik Inc.
Traci McCarty, 650/825-7182 |
